- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Renovacor correlates $11m
Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.
Aug 15, 2019Litera reads up on Doxly acquisition
Doxly has become the first exit for the IU Philanthropic Venture Fund after its acquisition by Litera Microsystems.
Aug 15, 2019GraphPad scribbles down SnapGene
SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.
Aug 14, 2019IURTC begins new era as IU Ventures
Indiana University's IURTC has become IU Ventures with a purview dedicated to administering the Philanthropic Venture Fund, angel network and entrepreneurial support services.
Aug 14, 2019Landos lands $60m
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
Aug 14, 2019Daily deal net: August 12, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 12, 2019Carisma dazzles with extended series A
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
Aug 12, 2019Corporates fuel Hydrogenious LOHC’s $19m round
Royal Vopak, Mitsubishi and Covestro helped the Erlangen–Nuremberg hydrogen storage technology spinout collect $19m in funding.
Aug 12, 2019Daily deal net: August 9, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 9, 2019Oxford Brain Diagnostics secures funding
Oxford Brain Diagnostics hopes to commercialise an early diagnosis tool for Alzheimer’s disease pioneered through eight years of University of Oxford research.
Aug 9, 2019Freiburg celebrates Cytena exit
Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.
Aug 9, 2019MedWhat court strikes down more discovery objections
Motion-to-compel fines have been served to parties from Stanford University and Stanford-StartX Fund for blocking MedWhat's discovery request in the ongoing legal case.
Aug 9, 2019Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


